Synthetic polyribonucleotides: current role and potential use in oncological practice
- 30 April 1995
- journal article
- review article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 21 (2) , 224-227
- https://doi.org/10.1016/s0748-7983(95)90930-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Characterization of immune suppression induced by polyribonucleotidesInternational Journal of Immunopharmacology, 1991
- Adjuvant treatment of operable stomach cancer with polyadenylic·polyuridylic acid in addition to chemotherapeutic agents: A preliminary reportInternational Journal of Immunopharmacology, 1990
- The association of impaired neutrophil chemotaxis with postoperative surgical sepsisBritish Journal of Surgery, 1986
- Effects of Chemotherapeutic Agents on the Immune Response. IICancer Investigation, 1985
- Possible role for C-reactive protein in the human natural killer cell response.The Journal of Experimental Medicine, 1983
- Immune impairment and metastatic tumor growth.The need for an immunorestorative drug as an adjunct to surgeryCancer, 1979
- Regulation of the immune system by synthetic polynucleotidesCellular Immunology, 1978
- Cytotoxic T-cell activation by polyribonucleotides: DNA synthesis is not required.The Journal of Experimental Medicine, 1977
- Nuclear penetration and stimulation of nucleic acids synthesis by poly(A)-poly(U) in mammalian cellsExperimental Cell Research, 1975
- Parameters for effective use of synthetic double stranded polynucleotides in the amplification of immunologically induced lymphocyte tritiated thymidine incorporationCellular Immunology, 1974